GRI Bio, Inc. (GRI)
NASDAQ: GRI · IEX Real-Time Price · USD
1.670
-0.080 (-4.57%)
At close: Jul 19, 2024, 4:00 PM
1.660
-0.010 (-0.60%)
Pre-market: Jul 22, 2024, 8:59 AM EDT
GRI Bio Employees
GRI Bio had 4 employees as of December 31, 2023. The number of employees increased by 3 or 300.00% compared to the previous year.
Employees
4
Change (1Y)
3
Growth (1Y)
300.00%
Revenue / Employee
n/a
Profits / Employee
-$3,193,500
Market Cap
1.01M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 4 | 3 | 300.00% |
| Dec 31, 2022 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| China SXT Pharmaceuticals | 78 |
| LogicMark | 27 |
| Biodexa Pharmaceuticals | 21 |
| Seelos Therapeutics | 16 |
| Bluejay Diagnostics | 10 |
| Dermata Therapeutics | 8 |
| Salarius Pharmaceuticals | 2 |
| Bone Biologics | 2 |
GRI News
- 7 days ago - GRI Bio (NASDAQ: GRI) to Participate in the Virtual Investor Lunch Break Series - GlobeNewsWire
- 10 days ago - GRI Bio (NASDAQ: GRI) Participates in Virtual Investor “What This Means” Segment - GlobeNewsWire
- 14 days ago - GRI Bio Regains Compliance with Nasdaq - GlobeNewsWire
- 20 days ago - GRI Bio Announces Publication of Positive Preclinical Data from Lead Program GRI-0621 in the American Journal of Respiratory and Critical Care Medicine - GlobeNewsWire
- 21 days ago - GRI Bio to Present at the 8th Annual IPF Summit - GlobeNewsWire
- 23 days ago - GRI Bio Announces Closing of $4.0 Million Public Offering - GlobeNewsWire
- 25 days ago - GRI Bio Announces Korea Patent Granted for Proprietary Natural Killer T (NKT) Cell Modulators - GlobeNewsWire
- 5 weeks ago - GRI Bio Announces Reverse Stock Split - GlobeNewsWire